Figure 1
From: A Pilot Study on Tocilizumab for Treating Refractory Adult-Onset Still’s Disease
Clinical efficacy and improvement of inflammatory markers after TCZ therapy.
Figure 1 | Scientific Reports
From: A Pilot Study on Tocilizumab for Treating Refractory Adult-Onset Still’s Disease
Clinical efficacy and improvement of inflammatory markers after TCZ therapy.
